Cerebrospinal fluid and serum chitotriosidase levels in patients with aneurysmal subarachnoid haemorrhage: Preliminary results

Turkish Neurosurgery

Volumn 17, Issue 4, 2007, Pages 235-242

  Işman, Ferruh Kemal ^a   Kacira, Tibet ^b   Kucur, Mine ^b   Sanus, Galip Zihni ^b   Atukeren, Pinar ^b   Tanriverdi, Taner ^b   Kaynar, Mehmet Yaşar ^b  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aneurysm; Chitotriosidase; Inflammation; Macrophage; Subarachnoid hemorrhage

Indexed keywords

CHITOTRIOSIDASE;

ADULT; AGED; ANEURYSM; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MACROPHAGE; MALE; NORMOTENSIVE HYDROCEPHALUS; SUBARACHNOID HEMORRHAGE; VASOSPASM;

EID: 37749027531     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aguilera B, Ghauharali-van der Vlught K, Helmond MT, et al. Transglycosidase activity of chitotriosidase; improved enzymatic assay for the human macrophage chitinase. J Biol Chem 2003; 278: 40911-917.
2. Artieda M, Cenarro A, Ganan A, et al. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003; 23: 1645-52.
3. Barone SS, Barone R, Zanda B, et al. Chitotriosidase in patients with acute ischemic stroke. Eur Neurol 2005; 54: 149-153.
4. Bierbaum S, Superti-Furga A, Heinzmann A. Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int J Immunogenetics 2006; 33: 201-4.
5. Boot RG, Renkema GH, Strijland A, et al. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 1995; 270: 26252-56.
6. Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene: nature of inherited enzyme deficiency. J Biol Chem 1998; 273: 25680-85.
7. Boot RG, van Achterberg TAE, van Aken BE, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19: 687-94.
8. Bouzas L, Guinarte JC, Tutor JC. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. J Clin Lab Analysis 2003; 17: 271-75.
9. Casal JA, Robles A, Tutor JC. Serum markers of monocyte/macrophage in patients with Alzheimer's disease and other types of dementia. Clinical Biochemistry 2003; 36: 553-56.
10. Civallero G, Michelin K, de Mari J, et al. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases. Clinica Chimica Acta 2006; 372: 98-102.
11. Czartoryska B, Fiszer U, Lugowska A. Chitotriosidase activity in cerebrospinal fluid as a parameter of inflammatory processes in neurological diseases. J Lab Med 2001; 25: 77-81.
12. Deegan PB, Moran MT, McFarlane I, et al. Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. Blood Cells, Molecules, and Diseases 2005; 35: 259-67.
13. Di Rosa M, Dell'Ombra N, Zambito AM, et al. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci 2006; 23: 2648-56.
14. Grasso G. An overview of pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Research Reviews 2004; 44: 49-63.
15. Grosso S, Margollicci MA, Bargagli E, et al. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 2004; 64: 57-62.
16. Guo Y, He W, Boer AM, et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 1995; 18: 717-22.
17. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with subarachnoid hemorrhage: A review. Neurosurgery 2005; 56: 633-54.
18. Hollak CEM, van Weely S, van Oers MHJ, et al. Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J Clin Invest 1994; 93: 1288-92.
19. Kaynar MY, Tanriverdi T, Kafadar AM, et al. YKL-40 Levels in the cerebrospinal fluid and serum of patients with aneurysmal subarachnoid hemorrhage: Preliminary Results. J Clin Neurosci 2005; 12: 754-57.
20. Palasik W, Fiszer U, Lechowicz W, et al. Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol 2005; 53: 188-193.
21. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacology and Therapeutics 2005; 105: 23-56.
22. Tharanathan RN and Kittur FS. Chitin-the undisputed biomolecule of great potential. Crit Rev Food Sci Nutr 2003; 43: 61-7.
23. van Eijik M, van Roomen CPAA, Renkema GH, et al. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 2005; 17: 1505-12.
24. Vedder AC, Cox-Brinkman J, Hollak CEM, et al. Plasma chitotriosidase in male Fabry patients: A marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Molecular Genetics and Metabolism 2006; 26: doi: 10.1016/j.ymgme.2006.04.013.
25. Vellodi A, Foo Y, Cole TJ. Evaluation of three biochemical markers in the monitoring of Gaucher disease. J Inherit Metab 2005; 28: 585-592
26. Wajner A, Michelin K, Burin MG, et al. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clinical Biochemistry 2004; 37: 893-97.